期刊论文详细信息
Molecular Systems Biology
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
Alejandro A Schäffer1  Eytan Ruppin1  Kuoyuan Cheng2  Sanju Sinha2  Eyal Schiff3  Kenneth Aldape4 
[1] Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA;Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA;Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA;Department of Obstetrics, Gynecology and Reproductive Sciences, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel‐Aviv University, Ramat Gan, Tel‐Aviv, Israel;Laboratory of Pathology, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA;
关键词: angiotensin I‐converting enzyme 2;    coronavirus disease 2019;    dexamethasone;    ACE;    severe acute respiratory syndrome coronavirus 2;   
DOI  :  10.15252/msb.20209628
来源: Wiley
PDF
【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202202053827299ZK.pdf 1038KB PDF download
  文献评价指标  
  下载次数:9次 浏览次数:4次